 |
Freedman R, Olincy A, Buchanan RW, Harris JG, Gold JM, Johnson L, Allensworth D, Guzman-Bonilla A, Clement B, Ball MP, Kutnick J, Pender V, Martin LF, Stevens KE, Wagner BD, Zerbe GO, Soti F, Kem WR.
Initial phase 2 trial of a nicotinic agonist in schizophrenia. Am J Psychiatry.
2008 Aug
;
165(8):1040-7.
Pubmed Abstract
|
I recommend the Primary Papers